In
this paper, a novel nanofilm type is proposed based on a blend of
poly(ethylene glycol)-block-poly(ε-caprolactone)
methyl ether (PEG-b-PCL) and poly(l-lactic
acid), doped with zinc oxide nanoparticles (ZnO NPs) at different
concentrations (0.1, 1, and 10 mg/mL). All nanofilm types were featured
by a thickness value of ∼500 nm. Increasing ZnO NP concentrations
implied larger roughness values (∼22 nm for the bare nanofilm
and ∼67 nm for the films with 10 mg/mL of NPs), larger piezoelectricity
(average d
33 coefficient for the film
up to ∼1.98 pm/V), and elastic modulus: the nanofilms doped
with 1 and 10 mg/mL of NPs were much stiffer than the nondoped controls
and nanofilms doped with 0.1 mg/mL of NPs. The ZnO NP content was
also directly proportional to the material melting point and crystallinity
and inversely proportional to the material degradation rate, thus
highlighting the stabilization role of ZnO particles. In vitro tests
were carried out with cells of the musculoskeletal apparatus (fibroblasts,
osteoblasts, chondrocytes, and myoblasts). All cell types showed good
adhesion and viability on all substrate formulations. Interestingly,
a higher content of ZnO NPs in the matrix demonstrated higher bioactivity,
boosting the metabolic activity of fibroblasts, myoblasts, and chondrocytes
and enhancing the osteogenic and myogenic differentiation. These findings
demonstrated the potential of these nanocomposite matrices for regenerative
medicine applications, such as tissue engineering.